Why Rhythm Pharmaceuticals Stock Triumphed on Tuesday
A standout quarterly report helped Rhythm Pharmaceuticals stock surge on Tuesday as investors embraced better-than-ex...
This piece outlines What To Buy After Tax Loss Harvest Dividend ETF, including replacement candidates and criteria to choose wisely.
23,181 articlesA standout quarterly report helped Rhythm Pharmaceuticals stock surge on Tuesday as investors embraced better-than-ex...
As markets swing in 2026, investors revisit Ted Turner's risk-taking era, drawing lessons on diversification, leverag...
Major DeFi protocols are migrating to Chainlink's CCIP after a $292 million KelpDAO exploit, pushing LINK higher as t...
A new Gallup analysis reveals a striking generational split in job optimism in the U.S., with young americans more pe...
Investors react to a key vote in the semiconductor space as IonQ jumps on the SkyWater deal. Here’s what it means for...
A rising wave of data centers and AI workloads is straining power grids. Learn how a strategic nuclear stock could ri...
Harrow Health's Q1 2026 earnings transcript offers more than numbers—it reveals management's execution plan and what ...
Ethereum sits around $2,150, facing a pivotal $2,400 hurdle. In ethereum price analysis: must terms, a clear reclaim ...
Two music icons are backing a major beagle adoption push, helping 1,500 dogs rescued from Ridglan Farms find new home...
April’s rent reading jumped 0.6% as the government finally catches up on a year of data, a quirk that has investors w...
The internet computer (icp) tumbles about 10% in a broad crypto selloff, weakening after Coinbase removed several ICP...
Iren has closed a $3 billion convertible notes sale at a 1% coupon, due 2033, to bankroll its AI cloud infrastructure...